Kinkead B, Nemeroff C B
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Ga 30322.
J Clin Psychiatry. 1994 Sep;55 Suppl B:30-2.
Several lines of evidence, including the effect of antipsychotic drugs on neurotensin-containing neurons, have implicated the neurotensin system in the mechanism of action of antipsychotic drugs. Thus far, all clinically efficacious antipsychotics have been found to increase neurotensin concentrations in the nucleus accumbens; "typical" antipsychotic drugs increase neurotensin concentrations in both the nucleus accumbens and the caudate nucleus, whereas "atypical" antipsychotics increase neurotensin concentrations only in the nucleus accumbens. The effects of antipsychotic drugs on neurotensin-containing neurons in the nucleus accumbens may be predictive of clinical antipsychotic efficacy whereas the effects on neurotensin in the caudate nucleus may be predictive of extrapyramidal side effects. In addition to this evidence that antipsychotic drugs may act at least in part on neurotensin-containing neurons to produce their clinical effects is a considerable data base indicating that there are alterations in neurotensin-containing neurons in schizophrenia.
包括抗精神病药物对含神经降压素神经元的作用在内的多项证据表明,神经降压素系统与抗精神病药物的作用机制有关。到目前为止,已发现所有临床有效的抗精神病药物都会增加伏隔核中的神经降压素浓度;“典型”抗精神病药物会增加伏隔核和尾状核中的神经降压素浓度,而“非典型”抗精神病药物仅会增加伏隔核中的神经降压素浓度。抗精神病药物对伏隔核中含神经降压素神经元的作用可能预示着临床抗精神病疗效,而对尾状核中神经降压素的作用可能预示着锥体外系副作用。除了抗精神病药物可能至少部分通过作用于含神经降压素神经元来产生临床效果这一证据外,还有大量数据库表明精神分裂症患者中含神经降压素神经元存在改变。